3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions (Nehb-STEMI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00623896|
Recruitment Status : Unknown
Verified June 2007 by Assaf-Harofeh Medical Center.
Recruitment status was: Recruiting
First Posted : February 26, 2008
Last Update Posted : February 26, 2008
The method of ECG recording with the use of three bipolar leads A (anterior), D dorsalis) and J (or I - inferior) was introduced in 1938 by German electrophysiologist W. Nehb. Being positioned on the chest in the immediate proximity to the heart, and being aligned to the anatomic position of the heart, these leads are very sensitive and allow accurate diagnostics of different heart conditions. All the active leads are placed on anterolateral plane of the chest wall requiring little anatomical window making this technique convenient for express diagnostics using compact electrocardiographic devices without any loss of valuable information.
Active electrodes are located on the chest in the following order: 1st- red standard electrode placed in the second intercostal space to the right from sternum corresponding to V1 for standard 12-lead ECG recording, 2nd- green standard lead placed in the position corresponding to V4; 3rd- yellow in the position V7. Then ECG recorded as if in the I standard lead would be defined as Nehb's D, which records the potential on the posterior left ventricle wall; II standard lead would produce Nehb's A which corresponds to the potential on the anterior wall of the left ventricle, and III standard lead would record Nehb's J, which reflects the potential on the diaphragmatic surface of heart.
Been simple and informative, this ECG recording modality may be applicable for usage with compact portable cardiographer devices for express diagnosis in different situations and may allow faster and more adequate outpatient response in the case of emergencies.
Nehb 3 leads ECG can provide the clinician with portable, reliable, comprehensive and constant ECG monitoring and by this facilitate rapid diagnosis and treatment of STEMI.
|Condition or disease|
|Acute Myocardial Infarction With ST Segment Elevation|
General Objective: to compare the diagnostic ability of Nehb 3 lead ECG and standard 12 lead ECG in patients presenting to EMS with STEMI.
Age ≥ 18 years ST elevation in more than 2 contiguous leads (> 1 mV in limb leads & V5-V6; more than 2 mm in V1-V4) Complains of chest, neck, jaw, arm, epigastric or back pain or dyspnea Patients directly transferred to the coronary care unit.
Unconscious patients Unwillingness to participate in the study Presence of LBBB
100 patients with STEMI will be included. After initial 12 leads ECG made by EMS personnel will show changes consistent with STEMI, a portable Nehb 3 leads (ECG MiniMonitor CG 5000 N) recorder will be connected to the patient. 12 leads ECG recording will be performed according to the EMS and the CCU practices, i.e: before transport, on admission, before and after reperfusion therapy (thrombolysis or PCI), during angina episodes, and every 24 hours since admission. Nehb tracing will be recorded in parallel with standard 12 leads ECG.
ECG findings of standard 12 leads ECG and Nehb 3 leads ECG will be compared for:
Presence of ST elevation (defined as presence of ST segment elevation in 2 or more contiguous leads in 12 leads ECG versus presence of ST segment elevation or depression in 1 or more leads in Nehb ECG).
Area at risk  (defined as sum of amplitudes of ST segment elevations of all leads that demonstrate this in 12 leads ECG versus sum of amplitudes of ST segment elevations of all leads in Nehb ECG)
Severity of ischemia  (defined as disappearance of S waves in leads with normally negative QRS or J point elevation over more than 50% of R wave height in leads with normally positive QRS in 12 leads versus Nehb ECG)
Time discrimination (defined as presence of ST segment elevation at any time of recording and total amount of such events by 12 leads ECG versus Nehb ECG).
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Nehb 3-Lead Bipolar Leads for Rapid Diagnosis & Treatment of STEMI|
|Study Start Date :||June 2007|
|Estimated Primary Completion Date :||May 2008|
|Estimated Study Completion Date :||August 2008|
- Evidence of ST Elevations in Nehb Tracing in all patients with determined STEMI in Standard 12-leads ECG. [ Time Frame: On patients' admition to EMS/ICCU ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00623896
|Contact: Ilya Litovchik, MDemail@example.com|
|Assaf Harofeh Medical Center Intensive Coronary Care Unit||Recruiting|
|Zerifin, Israel, 73000|
|Contact: Ilya Litovchik, MD +972577345900 firstname.lastname@example.org|
|Principal Investigator: Ilya Litovchik, MD|
|Sub-Investigator: Nicholas Teodorovich, MD|
|Principal Investigator:||Ilya Litovchik, MD||Assaf-Harofeh Medical Center|